Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, Richard A, Marayati, Raoud, Flate, Elizabeth L, Volmar, Keith E, Loeza, S Gabriela Herrera, Hoadley, Katherine A, Rashid, Naim U, Williams, Lindsay A +10 more·2015·Nature Genetics

DOI 10.1038/ng.3398

Cited by (1,002)

Items 301–400 of 1,002

Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
Dan He, Huijin Feng, Belen Sundberg, Jiaxing Yang, Justin Powers, Alec H. Christian, John Erby Wilkinson, Cian Monnin, Daina Zofija Avizonis, Craig J. Thomas et al. · 2022 · Molecular Cell
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses
Pawan Poudel, Gift Nyamundanda, Yatish Patil, Maggie C.U. Cheang, Anguraj Sadanandam · 2019 · npj Breast Cancer
Splice variants as novel targets in pancreatic ductal adenocarcinoma
Jun Wang, Laurent Dumartin, Andrea Mafficini, Pinar Ulug, Ajanthah Sangaralingam, Namaa Audi Alamiry, Tomasz P. Radon, Roberto Salvia, Rita Teresa Lawlor, Nicholas Robert Lemoine et al. · 2017 · Scientific Reports
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
Sandrina Martens, Pierre Lefesvre, Rémy Nicolle, Andrew Victor Biankin, Francesco Puleo, Jean‐Luc Van Laethem, Ilse Rooman · 2019 · Annals of Oncology
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression
Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang · 2021 · Cancer and Metastasis Reviews
Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
Umesh Ghoshdastider, Neha Rohatgi, Marjan Mojtabavi Naeini, Probhonjon Baruah, Egor Revkov, Yu Amanda Guo, Simone Rizzetto, Angeline M.L. Wong, Sundar Solai, Tin Trung Nguyen et al. · 2021 · Cancer Research
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Xu Zhou, Kai Hu, Peter J. Bailey, Christoph Springfeld, Susanne Roth, Roma Kurilov, Benedikt Brors, Thomas Mathias Gress, Malte Buchholz, Jingyu An et al. · 2021 · Frontiers in Cell and Developmental Biology
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
Xiang Zhang, Shangyou Zheng, Chonghui Hu, Guolin Li, Hongcao Lin, Renpeng Xia, Yuancheng Ye, Rihua He, Zhihua Li, Qing Lin et al. · 2022 · Oncogene
HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
Kalisz, Mark, Bernardo, Edgar, Beucher, Anthony, Maestro, Miguel Angel, del Pozo, Natalia, Millán, Irene, Haeberle, Lena, Schlensog, Martin, Safi, Sami Alexander, Knoefel, Wolfram Trudo et al. · 2020 · The EMBO Journal
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
Qiangda Chen, Ning Pu, Hanlin Yin, Jicheng Zhang, Guochao Zhao, Wenhui Lou, Wenchuan Wu · 2020 · Journal of Cellular and Molecular Medicine
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6
Shilpa Patil, Benjamin Steuber, Waltraut Kopp, Vijayalakshmi Kari, Laura Urbach, Xin Wang, Stefan Küffer, Hanibal Bohnenberger, Dimitra Spyropoulou, Zhe Zhang et al. · 2020 · Cancer Research
Immune response drives outcomes in prostate cancer: implications for immunotherapy
Jialin Meng, Yujie Zhou, Xiaofan Lu, Zichen Bian, Yiding Chen, Song Fan, Jun Zhou, Li Zhang, 郝宗耀, Meng Zhang et al. · 2020 · Molecular Oncology
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, Xiangsheng Liu · 2022 · ACS Nano
The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities
Yohei Masugi · 2022 · Cancers
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
Charlie Saillard, Flore Delecourt, Benoît Schmauch, Olivier Moindrot, Magali Svrcek, Armelle Bardier–Dupas, Jean‐François Emile, Mira Ayadi, Vinciane Rebours, Louis de Mestier et al. · 2023 · Nature Communications
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
Pierluigi Di Chiaro, Lucia Nacci, Fabiana Arco, Stefania Brandini, Sara Polletti, Andrea Palamidessi, Benedetta Donati, Chiara Soriani, Francesco Gualdrini, Gianmaria Frigè et al. · 2024 · Cancer Cell
Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor
Jeong‐Sun Seo, Ahreum Kim, Jong-Yeon Shin, Young Tae Kim · 2018 · Scientific Reports
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Tu, Bo, Yao, Jun, Ferri-Borgogno, Sammy, Zhao, Jun, Chen, Shujuan, Wang, Qiuyun, Yan, Liang, Zhou, Xin, Zhu, Cihui, Bang, Seungmin et al. · 2019 · JCI Insight
TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis
David Crottès, Yu-Hsiu Tony Lin, Christian J. Peters, John M. Gilchrist, Arun P. Wiita, Yuh Nung Jan, Lily Yeh Jan · 2019 · Proceedings of the National Academy of Sciences
Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies
Marina Ayres Pereira, Iok In Christine Chio · 2019 · Genes
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy
Qiang, Li, Hoffman, Megan T., Ali, Lestat R., Castillo, Jaime I., Kageler, Lauren, Temesgen, Ayantu, Lenehan, Patrick, Wang, S. Jennifer, Bello, Elisa, Cardot-Ruffino, Victoire et al. · 2023 · Gastroenterology
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis
Seongryong Kim, Galam Leem, Junjeong Choi, Yongjun Koh, Suho Lee, Sanghee Nam, Jin Su Kim, Chan Hee Park, Ho Kyoung Hwang, Kyoung Il Min et al. · 2024 · Genome Medicine
Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation
Evelyn Fessler, Jan Paul Medema · 2016 · Trends in cancer
Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical Outcomes
Kyuryung Kim, Sora Jeon, Tae‐Min Kim, Chan Kwon Jung · 2018 · Cancers
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
Samantha Ann Armstrong, Christopher William Schultz, Ariana Azimi-Sadjadi, Jonathan Robert Brody, Michael Jon Pishvaian · 2019 · Molecular Cancer Therapeutics
Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on
Caroline Sophie Verbeke, Lena Häberle, Daniela M. Lenggenhager, Iréne Esposito · 2018 · Pancreatology
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties
Ethan V. Abel, Masashi Goto, Brian Magnuson, Saji T. Abraham, Nikita Ramanathan, Emily Hotaling, Anthony A. Alaniz, Chandan Kumar‐Sinha, Michele L. Dziubinski, Sumithra Urs et al. · 2018 · eLife
Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes
Hyo Jeong Kang, Ji‐Hye Oh, Sung‐Min Chun, Deokhoon Kim, Yeon‐Mi Ryu, Hee Sang Hwang, Sang‐Yeob Kim, Jihyun An, Eun Jeong Cho, Hyeonjin Lee et al. · 2019 · Journal of Hepatology
Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis
Michael P. H. Tyler, Itay Tirosh · 2021 · Nature Communications
A comprehensive review of pancreatic cancer and its therapeutic challenges
Shan Jiang, Johan Bourghardt Fagman, Yunyun Ma, Jian Liu, Caroline Vihav, Cecilia Engström, Beidong Liu, Changyan Chen · 2022 · Aging
Morphological heterogeneity in ductal adenocarcinoma of the pancreas – Does it matter?
Caroline Sophie Verbeke · 2016 · Pancreatology
Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications
Robin John Lester Imperial, Omer M. Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood · 2017 · Seminars in Cancer Biology
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
Swati Venkat, Arwen A. Tisdale, Johann RE Schwarz, Abdulrahman A. Alahmari, H. Carlo Maurer, Kenneth P. Olive, Kevin Hasegawa Eng, Michael E. Feigin · 2020 · Genome Research
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma
Robert C. Grant, Robert Edward Denroche, Gun Ho Jang, Klaudia M. Nowak, Amy Xin Wei Zhang, Ayelet Borgida, Spring Holter, James Thomas Topham, Julie M. Wilson, Anna Dodd et al. · 2020 · Gut
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
Carmine Carbone, Geny Piro, Antonio Agostini, Pietro Delfino, Francesco De Sanctis, Vincenzo Nasca, Francesco Spallotta, Claudio Sette, Maurizio Martini, Stefano Ugel et al. · 2021 · Journal for ImmunoTherapy of Cancer
The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response
Henry C.-H. Law, Dragana Lagundžin, Emalie J. Clement, Fangfang Qiao, Zachary S. Wagner, Kimiko L. Krieger, Diane L. Costanzo-Garvey, Thomas C. Caffrey, Jean L. Grem, Dominick J. DiMaio et al. · 2019 · Clinical Cancer Research
Mechanisms of PDAC subtype heterogeneity and therapy response
Elisa Espinet, Lukas Klein, Ellen Puré, Shiv K. Singh · 2022 · Trends in cancer
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Lavanya Sivapalan, Hemant Mahendrakumar Kocher, Helen Ross‐Adams, Claude Chelala · 2020 · Pancreatology
High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
B. Ren, Jinshou Yang, Chengcheng Wang, Gang Yang, Huanyu Wang, Yuan-Hua Chen, Rui-Yuan Xu, Xuning Fan, L. You, Tai-Ping Zhang et al. · 2021 · Journal of Hematology & Oncology
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
Ergang Wang, Kun Xiang, Yun Zhang, Xiao‐Fan Wang · 2022 · Journal of the National Cancer Center
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration
Alexander T.F. Bell, Jacob T. Mitchell, Ashley L. Kiemen, Melissa R. Lyman, Kohei Fujikura, Jae Woo Lee, Erin M. Coyne, Sarah M. Shin, Sushma Nagaraj, Atul M. Deshpande et al. · 2024 · Cell Systems
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
Loretah Chibaya, Kelly D. DeMarco, Christina F. Lusi, Griffin I. Kane, Meghan L. Brassil, Chaitanya Naimesh Parikh, Katherine C. Murphy, Shreya R. Chowdhury, Junhui Li, Boyang Ma et al. · 2024 · Science Translational Medicine
Immunotherapy and pancreatic cancer: unique challenges and potential opportunities
Kate Young, Daniel Johnathan Hughes, David Cunningham, Naureen Starling · 2018 · Therapeutic Advances in Medical Oncology
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
Raffaella Casolino, Chiara Braconi, Giuseppe Malleo, Salvatore Paiella, Claudio Bassi, Michèle Milella, Stephan B. Dreyer, Fieke E. M. Froeling, David Kuang-Fu Chang, Andrew Victor Biankin et al. · 2020 · Annals of Oncology
Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
Zongyuan Yang, Xin Yang, Sen Xu, Ping Jin, Xiaoting Li, Wei Xiao, Dan Liu, Kecheng Huang, Sixiang Long, Ya Wang et al. · 2017 · Molecular Cancer
Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features
Changyu Zhu, Yu-Jui Ho, Marcela A. Salomao, Dianne H. Dapito, Alberto Bartolomé, Robert F. Schwabe, Ju‐Seog Lee, Scott W. Lowe, Utpal B. Pajvani · 2020 · Journal of Hepatology
Precision Oncology in Surgery
Stephan B. Dreyer, Mark Pinese, Nigel Balfour Jamieson, Christopher James Scarlett, Emily K. Colvin, Marina Pajic, Amber L. Johns, Jeremy L. Humphris, Jianmin Wu, Mark J. Cowley et al. · 2018 · Annals of Surgery
Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent manner
Hongzhen Li, Chunyan Peng, Chenhui Zhu, Shuang Nie, Xuetian Qian, Zhao Shi, Mengyue Shi, Liang Yan, Xiwei Ding, Shu Zhang et al. · 2021 · Clinical Epigenetics
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
Adam C. Mueller, Miles Piper, Andrew E. Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia, Andy V. Phan, Benjamin Van Court, Kathryn L. Zolman, Brisa Peña et al. · 2021 · Cancer Research
A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response
Alica K. Beutel, Lena Dorothee Schütte, Jeanette Scheible, Élodie Roger, Martin Müller, Lukas Perkhofer, Annika M. T. U. Kestler, Johann Michael Kraus, Hans Armin Kestler, Thomas F.E. Barth et al. · 2021 · Cancers
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Xu Zhou, Jingyu An, Roma Kurilov, Benedikt Brors, Kai Hu, Teresa Peccerella, Stephanie K. Roessler, Katrin Pfütze, Angela Schulz, Stephan Wolf et al. · 2023 · Nature Cancer
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC
Elena Fiorini, Antonia Malinova, Daniel Schreyer, Davide Pasini, Michele Bevere, Giorgia Alessio, Diego Rosa, Sabrina L. D’Agosto, Luca Azzolin, Salvatore Milite et al. · 2025 · Nature
Improving outcomes of patients with pancreatic cancer
Stephan B. Dreyer, Philip A. Beer, Sunil R. Hingorani, Andrew Victor Biankin · 2025 · Nature Reviews Clinical Oncology
Molecular Events in the Natural History of Pancreatic Cancer
Leslie E. Oldfield, Ashton Anthony Connor, Steve Gallinger · 2017 · Trends in cancer
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel · 2020 · Cancers
WNT Ligand Dependencies in Pancreatic Cancer
Kristina Y. Aguilera, David W. Dawson · 2021 · Frontiers in Cell and Developmental Biology
Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
Bo Ye, Dandan Fan, Weiwei Xiong, Min Li, Jian Yuan, Qi Jiang, Yuting Zhao, Jianxiang Lin, Jie Liu, Yilv Lv et al. · 2021 · Nature Communications
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
Theodore Evan, Victoria M.-Y. Wang, Axel Behrens · 2022 · Oncogene
Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma
Cindy Neuzillet, Rémy Nicolle, Jérôme Raffenne, Annemilaï Tijeras‐Raballand, Alexia Brunel, Lucile Astorgues‐Xerri, Sophie Vacher, Floriane Arbaretaz, Marjorie Fanjul, Marc Hilmi et al. · 2022 · The Journal of Pathology
Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential
Marta Sans, Yuki Makino, Jimin Min, Kimal Rajapakshe, Michele Yip-Schneider, Christian Max Schmidt, Mark W. Hurd, Jared K. Burks, Javier A. Gomez, Fredrik I. Thege et al. · 2023 · Cancer Discovery
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
Andreia V. Pinho, Mathias Van Bulck, Lorraine A. Chantrill, Mehreen Arshi, Tetyana Sklyarova, David Herrmann, Claire Vennin, David Gallego‐Ortega, Amanda Mawson, Marc Giry-Laterrière et al. · 2018 · Nature Communications
Organoid Models for Cancer Research
Hans C. Clevers, David A. Tuveson · 2019 · Annual Review of Cancer Biology
Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
Dhruba Kadel, Yu Zhang, Haoran Sun, Yue Zhao, Qiongzhu Dong, Lun‐Xiu Qin · 2019 · Cell Biology and Toxicology
Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
Natalia Anahi Juiz, Juan Iovanna, Nelson Dusetti · 2019 · Frontiers in Oncology
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target
Ritu Pandey, Muhan Zhou, Shariful Islam, Baowei Chen, Natalie K. Barker, Paul R. Langlais, Anup Srivastava, Moulun Luo, Laurence S. Cooke, Eric Weterings et al. · 2019 · Scientific Reports
Targeting Redox Metabolism in Pancreatic Cancer
Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, Alice Carrier · 2021 · International Journal of Molecular Sciences
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
Andreas Domen, Delphine Quatannens, Sara R. Zanivan, Christophe Deben, Jonas R.M. Van Audenaerde, Evelien Smits, An Wouters, Filip Lardon, Geert Roeyen, Yannick Verhoeven et al. · 2021 · Cancers
Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma
Ryota Chijimatsu, Shogo Kobayashi, Yu Takeda, Masatoshi Kitakaze, Shotaro Tatekawa, Yasuko Arao, Mika Nakayama, Naohiro Tachibana, Taku Saito, Daisuke Ennishi et al. · 2022 · iScience
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Yu-Huei Liu, Chun‐Mei Hu, Yuan-Sheng Hsu, Wen‐Hwa Lee · 2022 · Cell Death and Disease
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
Tara L. Hogenson, Hao Xie, William J. Phillips, Merih Deniz Toruner, Jing Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan Michael Carr et al. · 2022 · JCI Insight
An in vivo multiplexed small-molecule screening platform
Grüner, Barbara M, Schulze, Christopher J, Yang, Dian, Ogasawara, Daisuke, Dix, Melissa M, Rogers, Zoë N, Chuang, Chen-Hua, McFarland, Christopher D, Chiou, Shin-Heng, Brown, J Mark et al. · 2016 · Nature Methods
Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
Hagen Klett, Hannah Füllgraf, Ella Levit‐Zerdoun, Saskia Hussung, Silke Kowar, Simon Küsters, Peter Bronsert, Martin Werner, Uwe A. Wittel, Ralph Fritsch et al. · 2018 · Frontiers in Genetics
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery
Chad A. Barnes, Mariana I. Chavez, Susan Tsai, Mohammed Aldakkak, Ben George, Paul S. Ritch, Kulwinder S. Dua, Callisia Nathelee Clarke, Parag P. Tolat, Catherine E. Hagen et al. · 2019 · Surgery
Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer
Zhefang Wang, Jie Qin, Jiangang Zhao, Jiahui Li, Dai Li, Marie Christine Popp, Felix Popp, Hakan Alakus, Bo Kong, Qiongzhu Dong et al. · 2020 · Theranostics
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma
Vikas Somani, Daoxiang Zhang, Paarth B. Dodhiawala, Varintra E. Lander, Xiuting Liu, Liang‐I Kang, Hung-Po Chen, Brett L. Knolhoff, Lin Li, Patrick M. Grierson et al. · 2022 · Gastroenterology
From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer
Satvik Tripathi, Azadeh Tabari, Arian Mansur, Harika Dabbara, Christopher P. Bridge, Dania Daye · 2024 · Diagnostics
EMT and cancer: what clinicians should know
Erik W. Thompson, Andrew David Redfern, Simone Brabletz, Geert Berx, Veenoo Agarwal, Karuna Ganesh, Ruby Yun‐Ju Huang, Dana Ishay-Ronen, Pierre Savagner, Guojun Sheng et al. · 2025 · Nature Reviews Clinical Oncology
The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Hyunjin Park, Yangkyu Lee, Hye‐Jung Lee, Jin-Won Kim, Jin‐Hyeok Hwang, Jaihwan Kim, Yoo‐Seok Yoon, Ho‐Seong Han, Haeryoung Kim · 2017 · Tumor Biology
Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
Luís Arnes, Zhaoqi Liu, Jiguang Wang, H. Carlo Maurer, Irina R. Sagalovskiy, Marta Sánchez-Martín, Nikhil K. Bommakanti, Diana C. Garofalo, Dina A. Balderes, Lori Sussel et al. · 2018 · Gut
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Mirna Swayden, Juan Iovanna, Philippe Soubeyran · 2018 · Heliyon
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Tessa Y. S. Le Large, Giulia Mantini, Laura L. Meijer, Thang V. Pham, Niccola Funel, Nicole C.T. van Grieken, Bart Kok, Jaco C. Knol, Hanneke W.M. van Laarhoven, Sander R. Piersma et al. · 2020 · JCI Insight
Liquid biopsies for management of pancreatic cancer
Mohamadmahdi Samandari, María Gil Juliá, Alistair J. Rice, Antonios Chronopoulos, Armando E. del Río Hernández · 2018 · Translational research
Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis
Hisashi Yoshimura, Yoko Matsuda, Masami Yamamoto, Masaki Michishita, Kimimasa Takahashi, Norihiko Sasaki, Naoshi Ishikawa, Junko Aida, Kaiyo Takubo, Tomio Arai et al. · 2018 · Laboratory Investigation
Macroscopic onsite evaluation using endoscopic ultrasound fine needle biopsy as an alternative to rapid onsite evaluation
En–Ling Leung Ki, Anne‐Isabelle Lemaistre, Fabien Fumex, Rodica Gincul, Christine Lefort, Vincent Lépilliez, Bertrand Pujol, Bertrand Napoléon · 2019 · Endoscopy International Open
Liquid biopsy in pancreatic cancer: the beginning of a new era
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang · 2018 · Oncotarget
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
Wenhua Sang, Yiduo Zhou, Haiyan Chen, Chengxuan Yu, Lisi Dai, Zhongkun Liu, Lang Chen, Yimin Fang, Panpan Ma, Xiangji Wu et al. · 2023 · Cancer Discovery
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
Rong Tang, Jin Xu, Wei Wang, Qingcai Meng, Chenghao Shao, Yiyin Zhang, Yubin Lei, Zi-Feng Zhang, Yuan Liu, Qiong Du et al. · 2023 · Cell Reports Medicine
Neutrophil in the Pancreatic Tumor Microenvironment
Lin Jin, Hong Sun Kim, Jiaqi Shi · 2021 · Biomolecules
Intrapancreatic fat, pancreatitis, and pancreatic cancer
Anna C. Lilly, Igor A. Astsaturov, Erica A. Golemis · 2023 · Cellular and Molecular Life Sciences
Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth
Katelyn L. Donahue, Hannah R. Watkoske, Padma Kadiyala, Wenting Du, Kristee L. Brown, Michael K. Scales, Ahmed M. Elhossiny, Carlos E. Espinoza, Emily L. Lasse Opsahl, Brian D. Griffith et al. · 2024 · Cancer Discovery
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, Irina Sarró, Daniel Öhlund · 2024 · Biochemical Pharmacology
Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential
Erik S. Knudsen, Uthra Balaji, Elizaveta Freinkman, Peter A. McCue, Agnieszka Katarzyna Witkiewicz · 2016 · Oncotarget
Proteomic and genomic profiling of pancreatic cancer
Daniel Ansari, William Torén, Qimin Zhou, Dingyuan Hu, Roland E. Andersson · 2019 · Cell Biology and Toxicology
ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer
Tim D.D. Somerville, Yali Xu, Xiaoli Wu, Diogo Maia-Silva, Stella K. Hur, Larissa M. N. de Almeida, Jonathan B. Preall, Peter K. Koo, Christopher R. Vakoc · 2020 · Proceedings of the National Academy of Sciences
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma
Raju Kandimalla, Hideo Tomihara, Jasjit Kaur Banwait, Kensuke Yamamura, Gagandeep P. Singh, Hideo Baba, Ajay Goel · 2020 · Clinical Cancer Research
Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study
Jiang, Yuming, Liang, Xiaokun, Han, Zhen, Wang, Wei, Xi, Sujuan, Li, Tuanjie, Chen, Chuanli, Yuan, Qingyu, Li, Na, Yu, Jiang et al. · 2021 · The Lancet Digital Health
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
Patrick Michl, Matthias J. Löhr, John P. Neoptolemos, Gabriele Capurso, Vinciane Rebours, Núria Malats, Mathilde Ollivier, Luigi Ricciardiello · 2021 · United European Gastroenterology Journal
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Lingxi Jiang, Jiejie Qin, Yuting Dai, Shulin Zhao, Qian Zhan, Peng Cui, Lingjie Ren, Xuelong Wang, Ruihong Zhang, Chenxu Gao et al. · 2024 · Nature Medicine
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
Ivonne Regel, Julia V. Mayerle, Mahajan Ujjwal Mukund · 2020 · Cancers
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
Jialin Meng, Xiaofan Lu, Yujie Zhou, Meng Zhang, Qintao Ge, Jun Zhou, Zongyao Hao, Shenglin Gao, Fangrong Yan, Chang Yin Liang · 2021 · Molecular Therapy — Oncolytics